Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-22-006976
Filing Date
2022-03-16
Accepted
2022-03-16 16:08:13
Documents
1
Period of Report
2022-03-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3301
  Complete submission text file 0001493152-22-006976.txt   4949
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address
Vazzano Joseph Walter (Reporting) CIK: 0001715291 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15771 | Film No.: 22744947